Deal Announcements

APT Pharmaceuticals Adds $22 Million Funding

Friday, October 05, 2007 5:00:00 AM PDT | VentureDeal Staff

TUCSON, AZ -- APT Pharmaceuticals, Inc. announced that it has received $22 million in series A-2 funding from a syndicate of venture capital investors.

APT is a clinical stage biopharmaceutical company that is developing products to treat patients with asthma, chronic pulmonary obstructive disease, rhinitis and rhinovirus.

Investors in the round included Versant Ventures, Great Point Partners, Vivo Ventures and Charter Life Sciences Fund.  The company said it will use the proceeds to advance its development pipeline.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1